|
1
|
Dailey ME, Lindsay S and Skahen R:
Relation of thyroid neoplasms to Hashimoto disease of the thyroid
gland. AMA Arch Surg. 70:291–297. 1955. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee JH, Kim Y, Choi JW and Kim YS: The
association between papillary thyroid carcinoma and histologically
proven Hashimoto's thyroiditis: A meta-analysis. Eur J Endocrinol.
168:343–349. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang L, Li H, Ji QH, Zhu YX, Wang ZY,
Wang Y, Huang CP, Shen Q, Li DS and Wu Y: The clinical features of
papillary thyroid cancer in Hashimoto's thyroiditis patients from
an area with a high prevalence of Hashimoto's disease. BMC Cancer.
12:6102012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhang Y, Dai J, Wu T, Yang N and Yin Z:
The study of the coexistence of Hashimoto's thyroiditis with
papillary thyroid carcinoma. J Cancer Res Clin Oncol.
140:1021–1026. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeong JS, Kim HK, Lee CR, Park S, Park JH,
Kang SW, Jeong JJ, Nam KH, Chung WY and Park CS: Coexistence of
chronic lymphocytic thyroiditis with papillary thyroid carcinoma:
Clinical manifestation and prognostic outcome. J Korean Med Sci.
27:883–889. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jara SM, Carson KA, Pai SI, Agrawal N,
Richmon JD, Prescott JD, Dackiw A, Zeiger MA, Bishop JA and Tufano
RP: The relationship between chronic lymphocytic thyroiditis and
central neck lymph node metastasis in North American patients with
papillary thyroid carcinoma. Surgery. 154:1272–1282. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park JY, Kim DW, Park HK, Ha TK, Jung SJ,
Kim DH and Bae SK: Comparison of T stage, N stage, multifocality,
and bilaterality in papillary thyroid carcinoma patients according
to the presence of coexisting lymphocytic thyroiditis. Endocr Res.
40:151–155. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Muzza M, Degl'Innocenti D, Colombo C,
Perrino M, Ravasi E, Rossi S, Cirello V, Beck-Peccoz P, Borrello MG
and Fugazzola L: The tight relationship between papillary thyroid
cancer, autoimmunity and inflammation: clinical and molecular
studies. Clin Endocrinol (Oxf). 72:702–708. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Guo K and Wang Z: Risk factors influencing
the recurrence of papillary thyroid carcinoma: A systematic review
and meta-analysis. Int J Clin Exp Pathol. 7:5393–5403.
2014.PubMed/NCBI
|
|
10
|
Zhu J, Wang X, Zhang X, Li P and Hou H:
Clinicopathological features of recurrent papillary thyroid cancer.
Diagn Pathol. 10:962015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Gao L, Song C and Xie L: Incidence
of metastases from 524 patients with papillary thyroid carcinoma in
cervical lymph nodes posterior to the sternoclavicular joint (level
VIa): Relevance for endoscopic thyroidectomy. Surgery.
159:1557–1564. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Takami HE, Miyabe R and Kameyama K:
Hashimoto's thyroiditis. World J Surg. 32:688–692. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng C, Yi D, Zhou Y, Yao J, Chen B, Yang
C and Xu D: Differential diagnosis of non-diffuse primary thyroid
lymphoma and papillary thyroid carcinoma by ultrasound combined
with computed tomography. BMC Cancer. 22:9382022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ito Y, Kudo T, Kihara M, Takamura Y,
Kobayashi K, Miya A and Miyauchi A: Improvement of lymph node
recurrence rate, but not distant recurrence and carcinoma death
rates, in patients with papillary thyroid carcinoma after
disease-free survival for 5 years. Endocr J. 59:895–901. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
de Alcântara-Jones DM, de Alcântara-Nunes
TF, Rocha Bde O, de Oliveira RD, Santana AC, de Alcântara FT, de
Faria TM, da Silva IC and Araújo LM: Is there any association
between Hashimoto's thyroiditis and thyroid cancer? A retrospective
data analysis. Radiol Bras. 48:148–153. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Anil C, Goksel S and Gursoy A: Hashimoto's
thyroiditis is not associated with increased risk of thyroid cancer
in patients with thyroid nodules: A single-center prospective
study. Thyroid. 20:601–606. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Di Pasquale M, Rothstein JL and Palazzo
JP: Pathologic features of Hashimoto's-associated papillary thyroid
carcinomas. Hum Pathol. 32:24–30. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Intidhar Labidi S, Chaabouni AM, Kraiem T,
Attia N, Gritli S, El May A and Ben Slimane F: Thyroid carcinoma
and Hashimoto thyroiditis. Ann Otolaryngol Chir Cervicofac.
123:175–178. 2006.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Boelaert K, Horacek J, Holder RL,
Watkinson JC, Sheppard MC and Franklyn JA: Serum thyrotropin
concentration as a novel predictor of malignancy in thyroid nodules
investigated by fine-needle aspiration. J Clin Endocrinol Metab.
91:4295–4301. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang BY, Hseuh C, Chao TC, Lin KJ and Lin
JD: Well-differentiated thyroid carcinoma with concomitant
Hashimoto's thyroiditis present with less aggressive clinical stage
and low recurrence. Endocr Pathol. 22:144–149. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gupta S, Patel A, Folstad A, Fenton C,
Dinauer CA, Tuttle RM, Conran R and Francis GL: Infiltration of
differentiated thyroid carcinoma by proliferating lymphocytes is
associated with improved disease-free survival for children and
young adults. J Clin Endocrinol Metab. 86:1346–1354. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Matsubayashi S, Kawai K, Matsumoto Y,
Mukuta T, Morita T, Hirai K, Matsuzuka F, Kakudoh K, Kuma K and
Tamai H: The correlation between papillary thyroid carcinoma and
lymphocytic infiltration in the thyroid gland. J Clin Endocrinol
Metab. 80:3421–3424. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
American Thyroid Association (ATA)
Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid
Cancer, . Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL,
Mandel SJ, Mazzaferri EL, McIver B, Pacini F, et al: Revised
American thyroid association management guidelines for patients
with thyroid nodules and differentiated thyroid cancer. Thyroid.
19:1167–1214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Del Rio P, Cataldo S, Sommaruga L,
Concione L, Arcuri MF and Sianesi M: The association between
papillary carcinoma and chronic lymphocytic thyroiditis: Does it
modify the prognosis of cancer? Minerva Endocrinol. 33:1–5.
2008.PubMed/NCBI
|
|
26
|
Sugitani I, Kasai N, Fujimoto Y and
Yanagisawa A: A novel classification system for patients with PTC:
Addition of the new variables of large (3 cm or greater) nodal
metastases and reclassification during the follow-up period.
Surgery. 135:139–148. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Randolph GW, Duh QY, Heller KS, LiVolsi
VA, Mandel SJ, Steward DL, Tufano RP and Tuttle RM; American
Thyroid Association Surgical Affairs Committee's Taskforce on
Thyroid Cancer Nodal Surgery, : The prognostic significance of
nodal metastases from papillary thyroid carcinoma can be stratified
based on the size and number of metastatic lymph nodes, as well as
the presence of extranodal extension. Thyroid. 22:1144–1152. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Alpert EH, Wenig BM, Dewey EH, Su HK, Dos
Reis L and Urken ML: Size distribution of metastatic lymph nodes
with extranodal extension in patients with papillary thyroid
cancer: A pilot study. Thyroid. 25:238–241. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Stassi G, Todaro M, Zerilli M,
Ricci-Vitiani L, Di Liberto D, Patti M, Florena A, Di Gaudio F, Di
Gesù G and De Maria R: Thyroid cancer resistance to
chemotherapeutic drugs via autocrine production of interleukin-4
and interleukin-10. Cancer Res. 63:6784–6790. 2003.PubMed/NCBI
|
|
30
|
Oler G, Camacho CP, Hojaij FC, Michaluart
P Jr, Riggins GJ and Cerutti JM: Gene expression profiling of
papillary thyroid carcinoma identifies transcripts correlated with
BRAF mutational status and lymph node metastasis. Clin Cancer Res.
14:4735–4742. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wirtschafter A, Schmidt R, Rosen D, Kundu
N, Santoro M, Fusco A, Multhaupt H, Atkins JP, Rosen MR, Keane WM
and Rothstein JL: Expression of the RET/PTC fusion gene as a marker
for papillary carcinoma in Hashimoto's thyroiditis. Laryngoscope.
107:95–100. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Arif S, Blanes A and Diaz-Cano SJ:
Hashimoto's thyroiditis shares features with early papillary
thyroid carcinoma. Histopathology. 41:357–362. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bozec A, Lassalle S, Hofman V, Ilie M,
Santini J and Hofman P: The thyroid gland: A crossroad in
inflammation-induced carcinoma? An ongoing debate with new
therapeutic potential. Curr Med Chem. 17:3449–3461. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Unger P, Ewart M, Wang BY, Gan L, Kohtz DS
and Burstein DE: Expression of p63 in papillary thyroid carcinoma
and in Hashimoto's thyroiditis: A pathobiologic link? Hum Pathol.
34:764–769. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Burstein DE, Nagi C, Wang BY and Unger P:
Immunohistochemical detection of p53 homolog p63 in solid cell
nests, papillary thyroid carcinoma, and hashimoto's thyroiditis: A
stem cell hypothesis of papillary carcinoma oncogenesis. Hum
Pathol. 35:465–473. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
McCarthy RP, Wang M, Jones TD, Strate RW
and Cheng L: Molecular evidence for the same clonal origin of
multifocal papillary thyroid carcinomas. Clin Cancer Res.
12:2414–2418. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mazeh H, Samet Y, Hochstein D, Mizrahi I,
Ariel I, Eid A and Freund HR: Multifocality in well-differentiated
thyroid carcinomas calls for total thyroidectomy. Am J Surg.
201:770–775. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim KW, Park YJ, Kim EH, Park SY, Park DJ,
Ahn SH, Park DJ, Jang HC and Cho BY: Elevated risk of papillary
thyroid cancer in Korean patients with Hashimoto's thyroiditis.
Head Neck. 33:691–695. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Asanuma K, Sugenoya A, Kasuga Y, Itoh N,
Kobayashi S and Amano J: The relationship between multiple
intrathyroidal involvement in papillary thyroid carcinoma and
chronic non-specific thyroiditis. Cancer Lett. 122:177–180. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhu F, Shen YB, Li FQ, Fang Y, Hu L and Wu
YJ: The effects of hashimoto thyroiditis on lymph node metastases
in unifocal and multifocal papillary thyroid carcinoma: A
retrospective Chinese cohort study. Medicine (Baltimore).
95:e26742016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Banerjee S, Nahar U, Dahiya D, Mukherjee
S, Dey P, Gupta R, Radotra B, Sachdeva N, Sood A, Bhadada SK and
Bhansali A: Role of cytotoxic T cells and PD-1 immune checkpoint
pathway in papillary thyroid carcinoma. Front Endocrinol
(Lausanne). 13:9316472022. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liu Z, Wang L, Yi P, Wang CY and Huang T:
Risk factors for central lymph node metastasis of patients with
papillary thyroid microcarcinoma: A meta-analysis. Int J Clin Exp
Pathol. 7:932–937. 2014.PubMed/NCBI
|
|
43
|
Schindler AM, van Melle G, Evequoz B and
Scazziga B: Prognostic factors in papillary carcinoma of the
thyroid. Cancer. 68:324–330. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sherman SI, Brierley JD, Sperling M, Ain
KB, Bigos ST, Cooper DS, Haugen BR, Ho M, Klein I, Ladenson PW, et
al: Prospective multicenter study of thyroiscarcinoma treatment:
Initial analysis of staging and outcome. National thyroid cancer
treatment cooperative study registry group. Cancer. 83:1012–1021.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kuo SF, Lin SF, Chao TC, Hsueh C, Lin KJ
and Lin JD: Prognosis of multifocal papillary thyroid carcinoma.
Int J Endocrinol. 2013:8093822013. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kim HJ, Sohn SY, Jang HW, Kim SW and Chung
JH: Multifocality, but not bilaterality, is a predictor of disease
recurrence/persistence of papillary thyroid carcinoma. World J
Surg. 37:376–384. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Qu N, Zhang L, Ji QH, Zhu YX, Wang ZY,
Shen Q, Wang Y and Li DS: Number of tumor foci predicts prognosis
in papillary thyroid cancer. BMC Cancer. 14:9142014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Hay ID: Management of patients with
low-risk papillary thyroid carcinoma. Endocr Pract. 13:521–533.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Al Afif A, Williams BA, Rigby MH, Bullock
MJ, Taylor SM, Trites J and Hart RD: Multifocal papillary thyroid
cancer increases the risk of central lymph node metastasis.
Thyroid. 25:1008–1012. 2015. View Article : Google Scholar : PubMed/NCBI
|
